Company intelligence / Profile preview

Device of Tomorrow Capital

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Device of Tomorrow Capital (DOT Capital) is a venture capital firm focused on investing in early-stage technology and healthcare companies. The firm specifically targets innovative startups in the medical device, digital health, and technology-enabled service sectors. DOT Capital provides strategic guidance and capital to help entrepreneurs scale disruptive solutions that improve patient outcomes and healthcare efficiency. Their portfolio typically includes companies at the Seed to Series A stages that demonstrate high growth potential in the evolving healthcare landscape.

Industry: Investors

Beyond the preview

Go deeper on Device of Tomorrow Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Device of Tomorrow Capital.

Explore the full profile